Search research articles
Contact Us
Filters
Showing results (451-460 of 596) with videos related to
Page
of 60
Sort By:
European Journal of Heart Failure
|
May 22, 2022
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort
Marat Fudim, Peter S Fail, Sheldon E Litwin, et al.
Radiology
|
November 28, 2017
Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial
Michael T Lu, Nandini M Meyersohn, Thomas Mayrhofer, et al.
Clinical Cardiology
|
February 2, 2018
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
Ajar Kochar, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Journal of Cardiovascular Computed Tomography
|
December 27, 2016
Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR<sub>CT</sub> in Coronary Care (ADVANCE) registry
Kavitha M Chinnaiyan, Takashi Akasaka, Tetsuya Amano, et al.
Circulation
|
November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease
W Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
Circulation
|
June 5, 2014
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L Halperin, Graeme J Hankey, Daniel M Wojdyla, et al.
Journal of the American Heart Association
|
September 27, 2021
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial
Anthony P Carnicelli, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of Cardiac Failure
|
January 11, 2024
Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial
Marat Fudim, Sheldon E Litwin, Barry A Borlaug, et al.
Cardiology and Therapy
|
August 4, 2019
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF
Leo Ungar, Fatima Rodriguez, Anne S Hellkamp, et al.
American Heart Journal
|
September 26, 2006
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative
Manesh R Patel, Anita Y Chen, Eric D Peterson, et al.
Page
of 60
Search research articles
Search
Showing results (451-460 of 596) with videos related to
Sort By:
Page
of 60
European Journal of Heart Failure
|
May 22, 2022
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort
Marat Fudim, Peter S Fail, Sheldon E Litwin, et al.
Radiology
|
November 28, 2017
Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial
Michael T Lu, Nandini M Meyersohn, Thomas Mayrhofer, et al.
Clinical Cardiology
|
February 2, 2018
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
Ajar Kochar, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Journal of Cardiovascular Computed Tomography
|
December 27, 2016
Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFR<sub>CT</sub> in Coronary Care (ADVANCE) registry
Kavitha M Chinnaiyan, Takashi Akasaka, Tetsuya Amano, et al.
Circulation
|
November 15, 2016
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease
W Schuyler Jones, Iris Baumgartner, William R Hiatt, et al.
Circulation
|
June 5, 2014
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L Halperin, Graeme J Hankey, Daniel M Wojdyla, et al.
Journal of the American Heart Association
|
September 27, 2021
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial
Anthony P Carnicelli, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of Cardiac Failure
|
January 11, 2024
Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial
Marat Fudim, Sheldon E Litwin, Barry A Borlaug, et al.
Cardiology and Therapy
|
August 4, 2019
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF
Leo Ungar, Fatima Rodriguez, Anne S Hellkamp, et al.
American Heart Journal
|
September 26, 2006
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative
Manesh R Patel, Anita Y Chen, Eric D Peterson, et al.
Page
of 60